Cemiplimab Chinese instructions

1. Indications:

Cimepilimab is primarily used to treat advanced squamous cell non-small cell lung cancer (SCC), particularly in patients with high PD-L1 (programmed death ligand -1) expression. Additionally, it is approved for the treatment of a specific type of cutaneous squamous cell carcinoma (SCC).

2. Mechanism of action:

Cimipilimab is an immune checkpoint inhibitor that works mainly by blocking PD-1 (programmed death-1 in the immune system ) receptor and its ligand PD-L1 (programmed death ligand 1) to enhance the immune system's attack on cancer cells. PD-1 is an immune checkpoint receptor that exists on the surface of T lymphocytes and is used to maintain the balance of the immune system. When the PD-1 receptor binds to PD-L1, it inhibits the activity of T cells, weakens the immune response, and helps cancer cells evade attack by the immune system. The mechanism of action of cimipilimab is to relieve the inhibition of PD-1/PD-L1 communication, allowing activated T cells to more effectively identify, attack and eliminate cancer cells.

3. Pharmacology:

The pharmacological characteristics of cimepilimab include pharmacokinetics, pharmacodynamics and drug distribution, which are helpful to understand its performance and effects in the body.

4. Dosage and usage:

Patients should receive cimepilimab treatment under the guidance of a doctor. Usually, this medicine is given as an intravenous injection every 3 weeks. Specific adjustments in dosage will be based on the patient's weight and response to treatment. The duration of the treatment cycle will also vary based on the patient's specific condition.

5. Side effects:

The use of cimipilimab may cause a series of adverse reactions, including but not limited to: fatigue, rash, nausea, diarrhea, fever, loss of appetite, headache, muscle and joint pain, etc.

In addition, immune-related adverse events may also occur, including immune thyroid disease, pneumonia, liver function abnormalities, and intestinal inflammation. Patients need to be closely monitored for these potential adverse reactions while receiving treatment.

6. Warnings and precautions:

Patients need to pay attention to the following warnings and precautions when using cimepilimab:

1.Serious immune-related adverse events may occur, requiring regular monitoring and timely treatment.

2.It may affect normal immune response and increase the risk of infection.

3.It may have adverse effects on organs such as the thyroid, lungs, liver and intestines, and requires regular examination.

7. Contraindications:

Cimepilimab may not be suitable in certain circumstances, such as:

1.Patients who are allergic to drug ingredients.

2.Pregnant and breastfeeding women, unless the potential benefits clearly outweigh the potential risks.

8. Drug interactions:

Patients should inform their doctors about other drugs they are taking while taking cimepilimab, because some drugs may interact with it and affect the effectiveness of the treatment.

9. Medication for special groups:

1.Pediatric use: The safety and effectiveness of cimepilimab in children have not been fully established.

2.Dose for the elderly: Elderly patients usually require special attention because they may be more sensitive to adverse reactions.

3.Patients with liver and kidney dysfunction: The dosage needs to be adjusted according to the patient’s liver and kidney function.

10. Listing and price situation:

Cimeplimab is not currently available in China, so patients cannot purchase it domestically and need to purchase cimeplimab through overseas channels. There are only cimepri monoclonal original drugs abroad, mainly European and American versions. The European version is about 40,000, and the American version is about 100,000. Both are original drugs, and their drug ingredients and efficacy are the same.

Patients should follow their doctor's recommendations when using cimepilimab and undergo regular examinations and monitoring to ensure optimal treatment effects and reduce the risk of adverse reactions. Only under the clear guidance of a doctor can patients use this drug rationally in order to obtain the maximum benefit.